Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

Individual behavior at habitat edges may help populations persist in moving habitats.

MacDonald JS, Lutscher F.

J Math Biol. 2018 Dec;77(6-7):2049-2077. doi: 10.1007/s00285-018-1244-8. Epub 2018 May 8.

PMID:
29737397
2.

An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria.

Huang DB, Strader CD, MacDonald JS, VanArendonk M, Peck R, Holland T.

Open Forum Infect Dis. 2018 Jan 6;5(2):ofy003. doi: 10.1093/ofid/ofy003. eCollection 2018 Feb. Review.

3.

Time contracts and temporal precision declines when the mind wanders.

Terhune DB, Croucher M, Marcusson-Clavertz D, Macdonald JSP.

J Exp Psychol Hum Percept Perform. 2017 Nov;43(11):1864-1871. doi: 10.1037/xhp0000461.

PMID:
29072483
4.

Long-enduring primary hepatocyte-based co-cultures improve prediction of hepatotoxicity.

Novik EI, Dwyer J, Morelli JK, Parekh A, Cho C, Pludwinski E, Shrirao A, Freedman RM, MacDonald JS, Jayyosi Z.

Toxicol Appl Pharmacol. 2017 Dec 1;336:20-30. doi: 10.1016/j.taap.2017.09.013. Epub 2017 Sep 21.

PMID:
28942002
5.

Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach.

Farrell JJ, Moughan J, Wong JL, Regine WF, Schaefer P, Benson AB 3rd, Macdonald JS, Liu X, Yen Y, Lai R, Zheng Z, Bepler G, Guha C, Elsaleh H.

Pancreas. 2016 Nov;45(10):1485-1493.

6.

Attentional sampling of multiple wagon wheels.

Macdonald JS, Cavanagh P, VanRullen R.

Atten Percept Psychophys. 2014 Jan;76(1):64-72. doi: 10.3758/s13414-013-0555-5.

PMID:
24114356
7.

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.

Gordon MA, Gundacker HM, Benedetti J, Macdonald JS, Baranda JC, Levin WJ, Blanke CD, Elatre W, Weng P, Zhou JY, Lenz HJ, Press MF.

Ann Oncol. 2013 Jul;24(7):1754-61. doi: 10.1093/annonc/mdt106. Epub 2013 Mar 22.

8.

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS.

J Clin Oncol. 2012 Jul 1;30(19):2327-33. doi: 10.1200/JCO.2011.36.7136. Epub 2012 May 14.

9.

Perceptual echoes at 10 Hz in the human brain.

VanRullen R, Macdonald JS.

Curr Biol. 2012 Jun 5;22(11):995-9. doi: 10.1016/j.cub.2012.03.050. Epub 2012 May 3.

10.

Gastric cancer: Nagoya is not New York.

Macdonald JS.

J Clin Oncol. 2011 Nov 20;29(33):4348-50. doi: 10.1200/JCO.2011.37.5691. Epub 2011 Oct 17. No abstract available.

PMID:
22010021
11.

Trial-by-Trial Variations in Subjective Attentional State are Reflected in Ongoing Prestimulus EEG Alpha Oscillations.

Macdonald JS, Mathan S, Yeung N.

Front Psychol. 2011 May 10;2:82. doi: 10.3389/fpsyg.2011.00082. eCollection 2011.

12.

Visual perceptual load induces inattentional deafness.

Macdonald JS, Lavie N.

Atten Percept Psychophys. 2011 Aug;73(6):1780-9. doi: 10.3758/s13414-011-0144-4.

13.

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Rich TA, Willett CG.

Ann Surg Oncol. 2011 May;18(5):1319-26. doi: 10.1245/s10434-011-1630-6. Epub 2011 Mar 10.

14.

Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):809-16. doi: 10.1016/j.ijrobp.2010.11.039. Epub 2011 Feb 1.

15.

Adopting postoperative chemoradiotherapy in resected gastric cancer.

Macdonald JS.

Gastrointest Cancer Res. 2009 Nov;3(6):245-6. No abstract available.

16.

The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.

Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1328-35. doi: 10.1016/j.ijrobp.2010.07.1993. Epub 2010 Oct 8.

17.

Human and environmental health challenges for the next decade (2010–2020).

Bonnefoi MS, Belanger SE, Devlin DJ, Doerrer NG, Embry MR, Fukushima S, Harpur ES, Hines RN, Holsapple MP, Kim JH, MacDonald JS, O'Lone R, Pettit SD, Stevens JL, Takei AS, Tinkle SS, van der Laan JW.

Crit Rev Toxicol. 2010 Nov;40(10):893-911. doi: 10.3109/10408444.2010.506640. Review.

PMID:
20854192
18.

S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach.

Blanke CD, Chansky K, Christman KL, Hundahl SA, Issell BF, Van Veldhuizen PJ Jr, Budd GT, Abbruzzese JL, Macdonald JS.

Am J Clin Oncol. 2010 Apr;33(2):117-20. doi: 10.1097/COC.0b013e318199fb84.

19.

A data-based assessment of alternative strategies for identification of potential human cancer hazards.

Boobis AR, Cohen SM, Doerrer NG, Galloway SM, Haley PJ, Hard GC, Hess FG, Macdonald JS, Thibault S, Wolf DC, Wright J.

Toxicol Pathol. 2009 Oct;37(6):714-32. doi: 10.1177/0192623309343779. Epub 2009 Aug 21.

PMID:
19700658
20.

Toxicity testing in the 21st century: a view from the pharmaceutical industry.

MacDonald JS, Robertson RT.

Toxicol Sci. 2009 Jul;110(1):40-6. doi: 10.1093/toxsci/kfp088. Epub 2009 May 12. No abstract available.

PMID:
19435982
21.

An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approach.

Halleck M, Davis HR, Kirschmeier P, Levitan D, Snyder RD, Treinen K, Macdonald JS.

Toxicology. 2009 Apr 28;258(2-3):116-30. doi: 10.1016/j.tox.2009.01.017. Epub 2009 Jan 22.

PMID:
19428931
22.

Load induced blindness.

Macdonald JS, Lavie N.

J Exp Psychol Hum Percept Perform. 2008 Oct;34(5):1078-91. doi: 10.1037/0096-1523.34.5.1078.

23.

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA.

JAMA. 2008 Mar 5;299(9):1019-26. doi: 10.1001/jama.299.9.1019. Erratum in: JAMA. 2008 Apr 23/30;299(16):1902.

PMID:
18319412
24.

Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract.

Mahtani RL, Macdonald JS.

Oncologist. 2008 Jan;13(1):39-50. doi: 10.1634/theoncologist.2006-0049. Review.

25.

Lipid reserve dynamics and magnification of persistent organic pollutants in spawning sockeye salmon (Oncorhynchus nerka) from the Fraser River, British Columbia.

Kelly BC, Gray SL, Ikonomou MG, Macdonald JS, Bandiera SM, Hrycay EG.

Environ Sci Technol. 2007 May 1;41(9):3083-9.

PMID:
17539508
26.

Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.

Isacoff WH, Bendetti JK, Barstis JJ, Jazieh AR, Macdonald JS, Philip PA.

J Clin Oncol. 2007 May 1;25(13):1665-9.

PMID:
17470859
27.

Impact of hospital volume on recurrence and survival after surgery for gastric cancer.

Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS.

Ann Surg. 2007 Mar;245(3):426-34.

28.

Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.

Douglass HO Jr, Hundahl SA, Macdonald JS, Khatri VP.

Surg Oncol Clin N Am. 2007 Jan;16(1):133-55. Review.

PMID:
17336241
29.

Gastroesophageal cancer: understanding the disease process and advancing therapy.

Macdonald JS.

Gastrointest Cancer Res. 2007 Mar;1(2 Suppl):S1-3. No abstract available.

30.

Applying mechanisms of chemical toxicity to predict drug safety.

Guengerich FP, MacDonald JS.

Chem Res Toxicol. 2007 Mar;20(3):344-69. Epub 2007 Feb 16. Review.

PMID:
17302443
31.

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr; ASCO.

J Clin Oncol. 2006 Nov 20;24(33):5313-27. Epub 2006 Oct 23.

PMID:
17060676
32.

Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.

Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB 3rd, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS.

J Clin Oncol. 2006 Aug 1;24(22):3542-7.

PMID:
16877719
33.

Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.

Doroshow JH, McCoy S, Macdonald JS, Issell BF, Patel T, Cobb PW, Yost KJ, Abbruzzese JL.

Invest New Drugs. 2006 Nov;24(6):537-42.

PMID:
16832602
34.

Gastric cancer--new therapeutic options.

Macdonald JS.

N Engl J Med. 2006 Jul 6;355(1):76-7. No abstract available.

PMID:
16822999
35.

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.

Whitehead RP, McCoy S, Macdonald JS, Rivkin SE, Neubauer MA, Dakhil SR, Lenz HJ, Tanaka MS, Abbruzzese JL; Southwest Oncology Group.

Invest New Drugs. 2006 Jul;24(4):335-41.

PMID:
16683076
36.

Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.

Unger JM, Coltman CA Jr, Crowley JJ, Hutchins LF, Martino S, Livingston RB, Macdonald JS, Blanke CD, Gandara DR, Crawford ED, Albain KS.

J Clin Oncol. 2006 Jan 1;24(1):141-4. Epub 2005 Dec 5.

PMID:
16330670
37.

Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG.

J Clin Oncol. 2005 Dec 1;23(34):8706-12.

PMID:
16314630
38.

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, Mayer RJ.

J Clin Oncol. 2005 Dec 1;23(34):8671-8.

PMID:
16314627
39.

Home from home: residents' opinions of nursing homes and long-stay wards.

Higgs PF, MacDonald LD, MacDonald JS, Ward MC.

Age Ageing. 1998 Mar;27(2):199-205.

PMID:
16296680
40.
41.

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study.

Macdonald JS, McCoy S, Whitehead RP, Iqbal S, Wade JL 3rd, Giguere JK, Abbruzzese JL.

Invest New Drugs. 2005 Oct;23(5):485-7.

PMID:
16133800
42.

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, Park SH, Lee SH, Kim K, Park JO, Kim WS, Jung CW, Park YS, Im YH, Sohn TS, Noh JH, Heo JS, Kim YI, Park CK, Park K.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1279-85. Epub 2005 Aug 15.

PMID:
16099596
43.

Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.

Leichman CG, Benedetti JK, Zalupski MM, Hochster H, Shields AF, Lenz HJ, Wade Iii JL, Bearden Iii JD, Macdonald JS.

Clin Colorectal Cancer. 2005 Jul;5(2):119-23.

PMID:
16098253
44.

Role of post-operative chemoradiation in resected gastric cancer.

Macdonald JS.

J Surg Oncol. 2005 Jun 1;90(3):166-70. Review.

PMID:
15895449
45.
46.
47.

The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.

MacDonald JS, Halleck MM.

Toxicol Pathol. 2004 Jul-Aug;32 Suppl 2:26-41. Review.

PMID:
15503662
48.

Clinical overview: adjuvant therapy of gastrointestinal cancer.

Macdonald JS.

Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S4-11. Review.

PMID:
15309508
49.

Treatment of localized gastric cancer.

Macdonald JS.

Semin Oncol. 2004 Aug;31(4):566-73. Review.

PMID:
15297947
50.

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.

Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Williamson S, Gaynor ER, Balcerzak SP, Macdonald JS.

Invest New Drugs. 2004 Nov;22(4):467-73.

PMID:
15292717

Supplemental Content

Loading ...
Support Center